{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T18:19:36Z","timestamp":1772821176470,"version":"3.50.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,1,3]]},"DOI":"10.7759\/cureus.51605","type":"journal-article","created":{"date-parts":[[2024,1,4]],"date-time":"2024-01-04T00:07:51Z","timestamp":1704326871000},"source":"Crossref","is-referenced-by-count":2,"title":["A Rare Case of Adult Poorly Differentiated Chordoma of the Skull Base With Rapid Progression and Systemic Metastasis: A Review of the Literature"],"prefix":"10.7759","author":[{"given":"Keisuke","family":"Harada","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Shinojima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haruaki","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mai","family":"Itoyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daichi","family":"Uchida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuji","family":"Dekita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoru","family":"Miyamaru","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Uetani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yorihisa","family":"Orita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiki","family":"Mikami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kisato","family":"Nosaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshinori","family":"Hirai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akitake","family":"Mukasa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.4322\/acr.2019.120","article-title":"Metastatic poorly differentiated chordoma: the eyes do not see what the mind does not know","volume":"9","author":"Jaber OI","year":"2019","unstructured":"Jaber OI, Ashhab MA. Metastatic poorly differentiated chordoma: the eyes do not see what the mind does not know. Autops Case Rep. 2019, 9:e2019120. 10.4322\/acr.2019.120","journal-title":"Autops Case Rep"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1002\/path.1969","article-title":"Brachyury, a crucial regulator of notochordal development, is a novel biomarker for chordomas","volume":"209","author":"Vujovic S","year":"2006","unstructured":"Vujovic S, Henderson S, Presneau N, et al.. Brachyury, a crucial regulator of notochordal development, is a novel biomarker for chordomas. J Pathol. 2006, 209:157-65. 10.1002\/path.1969","journal-title":"J Pathol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1080\/10790268.2018.1483593","article-title":"Surgical management of chordoma: a systematic review","volume":"43","author":"Denaro L","year":"2020","unstructured":"Denaro L, Berton A, Ciuffreda M, Loppini M, Candela V, Brandi ML, Longo UG. Surgical management of chordoma: a systematic review. J Spinal Cord Med. 2020, 43:797-812. 10.1080\/10790268.2018.1483593","journal-title":"J Spinal Cord Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3109\/02688697.2010.546896","article-title":"A comprehensive analysis of intracranial chordoma and survival: a systematic review","volume":"25","author":"Jian BJ","year":"2011","unstructured":"Jian BJ, Bloch OG, Yang I, Han SJ, Aranda D, Parsa AT. A comprehensive analysis of intracranial chordoma and survival: a systematic review. Br J Neurosurg. 2011, 25:446-53. 10.3109\/02688697.2010.546896","journal-title":"Br J Neurosurg"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0000000000000462","article-title":"Nuclear brachyury expression is consistent in chordoma, common in germ cell tumors and small cell carcinomas, and rare in other carcinomas and sarcomas: an immunohistochemical study of 5229 cases","volume":"39","author":"Miettinen M","year":"2015","unstructured":"Miettinen M, Wang Z, Lasota J, Heery C, Schlom J, Palena C. Nuclear brachyury expression is consistent in chordoma, common in germ cell tumors and small cell carcinomas, and rare in other carcinomas and sarcomas: an immunohistochemical study of 5229 cases. Am J Surg Pathol. 2015, 39:1305-12. 10.1097\/PAS.0000000000000462","journal-title":"Am J Surg Pathol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-010-0767-x","article-title":"Loss of SMARCB1\/INI1 expression in poorly differentiated chordomas","volume":"120","author":"Mobley BC","year":"2010","unstructured":"Mobley BC, McKenney JK, Bangs CD, et al.. Loss of SMARCB1\/INI1 expression in poorly differentiated chordomas. Acta Neuropathol. 2010, 120:745-53. 10.1007\/s00401-010-0767-x","journal-title":"Acta Neuropathol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.anndiagpath.2021.151760","article-title":"Patterns of brachyury expression in chordomas","volume":"53","author":"Dridi M","year":"2021","unstructured":"Dridi M, Boutonnat J, Dumollard JM, Peoc'h M, Karpathiou G. Patterns of brachyury expression in chordomas. Ann Diagn Pathol. 2021, 53:151760. 10.1016\/j.anndiagpath.2021.151760","journal-title":"Ann Diagn Pathol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/apm.12978","article-title":"Poorly differentiated chordoma: review of 53 cases","volume":"127","author":"Yeter HG","year":"2019","unstructured":"Yeter HG, Kosemehmetoglu K, Soylemezoglu F. Poorly differentiated chordoma: review of 53 cases. APMIS. 2019, 127:607-15. 10.1111\/apm.12978","journal-title":"APMIS"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-019-03239-3","article-title":"Treatment of dedifferentiated chordoma: a retrospective study from a large volume cancer center","volume":"144","author":"Nachwalter RN","year":"2019","unstructured":"Nachwalter RN, Rothrock RJ, Katsoulakis E, et al.. Treatment of dedifferentiated chordoma: a retrospective study from a large volume cancer center. J Neurooncol. 2019, 144:369-76. 10.1007\/s11060-019-03239-3","journal-title":"J Neurooncol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-018-0522-4","article-title":"Clinical significance of polyglutamylation in primary central nervous system lymphoma","volume":"6","author":"Shinojima N","year":"2018","unstructured":"Shinojima N, Fujimoto K, Makino K, et al.. Clinical significance of polyglutamylation in primary central nervous system lymphoma. Acta Neuropathol Commun. 2018, 6:15. 10.1186\/s40478-018-0522-4","journal-title":"Acta Neuropathol Commun"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s10014-023-00461-w","article-title":"Lynch syndrome-associated chordoma with high tumor mutational burden and significant response to immune checkpoint inhibitors","volume":"40","author":"Shinojima N","year":"2023","unstructured":"Shinojima N, Ozono K, Yamamoto H, et al.. Lynch syndrome-associated chordoma with high tumor mutational burden and significant response to immune checkpoint inhibitors. Brain Tumor Pathol. 2023, 40:185-90. 10.1007\/s10014-023-00461-w","journal-title":"Brain Tumor Pathol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.5414\/NP300724","article-title":"Anaplastic chordoma with loss of INI1 and brachyury expression in a 2-year-old girl","volume":"33","author":"Chavez JA","year":"2014","unstructured":"Chavez JA, Nasir Ud Din, Memon A, Perry A. Anaplastic chordoma with loss of INI1 and brachyury expression in a 2-year-old girl. Clin Neuropathol. 2014, 33:418-20. 10.5414\/NP300724","journal-title":"Clin Neuropathol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.cancergen.2014.05.005","article-title":"Non-rhabdoid pediatric SMARCB1-deficient tumors: overlap between chordomas and malignant rhabdoid tumors?","volume":"207","author":"Renard C","year":"2014","unstructured":"Renard C, Pissaloux D, Decouvelaere AV, Bourdeaut F, Ranch\u00e8re D. Non-rhabdoid pediatric SMARCB1-deficient tumors: overlap between chordomas and malignant rhabdoid tumors?. Cancer Genet. 2014, 207:384-9. 10.1016\/j.cancergen.2014.05.005","journal-title":"Cancer Genet"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/not228","article-title":"Prognostic value of MIB-1, p53, epidermal growth factor receptor, and INI1 in childhood chordomas","volume":"16","author":"Yadav R","year":"2014","unstructured":"Yadav R, Sharma MC, Malgulwar PB, et al.. Prognostic value of MIB-1, p53, epidermal growth factor receptor, and INI1 in childhood chordomas. Neuro Oncol. 2014, 16:372-81. 10.1093\/neuonc\/not228","journal-title":"Neuro Oncol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-016-1574-9","article-title":"Poorly differentiated chordoma with SMARCB1\/INI1 loss: a distinct molecular entity with dismal prognosis","volume":"132","author":"Hasselblatt M","year":"2016","unstructured":"Hasselblatt M, Thomas C, Hovestadt V, et al.. Poorly differentiated chordoma with SMARCB1\/INI1 loss: a distinct molecular entity with dismal prognosis. Acta Neuropathol. 2016, 132:149-51. 10.1007\/s00401-016-1574-9","journal-title":"Acta Neuropathol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0000000000000741","article-title":"SMARCB1\/INI1 involvement in pediatric chordoma: a mutational and immunohistochemical analysis","volume":"41","author":"Antonelli M","year":"2017","unstructured":"Antonelli M, Raso A, Mascelli S, et al.. SMARCB1\/INI1 involvement in pediatric chordoma: a mutational and immunohistochemical analysis. Am J Surg Pathol. 2017, 41:56-61. 10.1097\/PAS.0000000000000741","journal-title":"Am J Surg Pathol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1111\/neup.12407","article-title":"Poorly differentiated chordoma with loss of SMARCB1\/INI1 expression in pediatric patients: a report of two cases and review of the literature","volume":"38","author":"Cha YJ","year":"2018","unstructured":"Cha YJ, Hong CK, Kim DS, Lee SK, Park HJ, Kim SH. Poorly differentiated chordoma with loss of SMARCB1\/INI1 expression in pediatric patients: a report of two cases and review of the literature. Neuropathology. 2018, 38:47-53. 10.1111\/neup.12407","journal-title":"Neuropathology"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1177\/1066896918768043","article-title":"Poorly differentiated chordomas showing loss of INI1\/SMARCB1: a report of 2 rare cases with diagnostic implications","volume":"26","author":"Rekhi B","year":"2018","unstructured":"Rekhi B, Kosemehmetoglu K, Rane S, Soylemezoglu F, Bulut E. Poorly differentiated chordomas showing loss of INI1\/SMARCB1: a report of 2 rare cases with diagnostic implications. Int J Surg Pathol. 2018, 26:637-43. 10.1177\/1066896918768043","journal-title":"Int J Surg Pathol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1002\/gcc.22511","article-title":"High sensitivity of FISH analysis in detecting homozygous SMARCB1 deletions in poorly differentiated chordoma: a clinicopathologic and molecular study of nine cases","volume":"57","author":"Owosho AA","year":"2018","unstructured":"Owosho AA, Zhang L, Rosenblum MK, Antonescu CR. High sensitivity of FISH analysis in detecting homozygous SMARCB1 deletions in poorly differentiated chordoma: a clinicopathologic and molecular study of nine cases. Genes Chromosomes Cancer. 2018, 57:89-95. 10.1002\/gcc.22511","journal-title":"Genes Chromosomes Cancer"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1038\/s41379-018-0002-1","article-title":"Clinicopathologic characteristics of poorly differentiated chordoma","volume":"31","author":"Shih AR","year":"2018","unstructured":"Shih AR, Cote GM, Chebib I, et al.. Clinicopathologic characteristics of poorly differentiated chordoma. Mod Pathol. 2018, 31:1237-45. 10.1038\/s41379-018-0002-1","journal-title":"Mod Pathol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1097\/PAI.0000000000000554","article-title":"A diagnostic pitfall: atypical teratoid rhabdoid tumor versus dedifferentiated\/poorly differentiated chordoma: analysis of a mono-institutional series","volume":"27","author":"Buccoliero AM","year":"2019","unstructured":"Buccoliero AM, Caporalini C, Scagnet M, et al.. A diagnostic pitfall: atypical teratoid rhabdoid tumor versus dedifferentiated\/poorly differentiated chordoma: analysis of a mono-institutional series. Appl Immunohistochem Mol Morphol. 2019, 27:147-54. 10.1097\/PAI.0000000000000554","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-18-3133","article-title":"Immunologic correlates of the abscopal effect in a SMARCB1\/INI1-negative poorly differentiated chordoma after EZH2 inhibition and radiotherapy","volume":"25","author":"Gounder MM","year":"2019","unstructured":"Gounder MM, Zhu G, Roshal L, et al.. Immunologic correlates of the abscopal effect in a SMARCB1\/INI1-negative poorly differentiated chordoma after EZH2 inhibition and radiotherapy. Clin Cancer Res. 2019, 25:2064-71. 10.1158\/1078-0432.CCR-18-3133","journal-title":"Clin Cancer Res"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1002\/gcc.22895","article-title":"Poorly differentiated chordoma with whole-genome doubling evolving from a SMARCB1-deficient conventional chordoma: a case report","volume":"60","author":"Curcio C","year":"2021","unstructured":"Curcio C, Cimera R, Aryeequaye R, Rao M, Fabbri N, Zhang Y, Hameed M. Poorly differentiated chordoma with whole-genome doubling evolving from a SMARCB1-deficient conventional chordoma: a case report. Genes Chromosomes Cancer. 2021, 60:43-8. 10.1002\/gcc.22895","journal-title":"Genes Chromosomes Cancer"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2021.03.001","article-title":"Brachyury expression in intracranial SMARCB1-deficient tumors: important points for distinguishing poorly differentiated chordoma from atypical teratoid\/rhabdoid tumor","volume":"112","author":"Kohashi K","year":"2021","unstructured":"Kohashi K, Yamamoto H, Yamada Y, Kinoshita I, Oda Y. Brachyury expression in intracranial SMARCB1-deficient tumors: important points for distinguishing poorly differentiated chordoma from atypical teratoid\/rhabdoid tumor. Hum Pathol. 2021, 112:1-8. 10.1016\/j.humpath.2021.03.001","journal-title":"Hum Pathol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.anndiagpath.2021.151809","article-title":"Poorly differentiated chordoma showing loss of SMARCB1\/INI1: clinicopathological and radiological spectrum of nine cases, including uncommon features of a relatively under-recognized entity","volume":"55","author":"Rekhi B","year":"2021","unstructured":"Rekhi B, Michal M, Ergen FB, et al.. Poorly differentiated chordoma showing loss of SMARCB1\/INI1: clinicopathological and radiological spectrum of nine cases, including uncommon features of a relatively under-recognized entity. Ann Diagn Pathol. 2021, 55:151809. 10.1016\/j.anndiagpath.2021.151809","journal-title":"Ann Diagn Pathol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1093\/ajcp\/aqaa223","article-title":"Cytomorphologic spectrum of SMARCB1-deficient soft tissue neoplasms","volume":"156","author":"Schaefer IM","year":"2021","unstructured":"Schaefer IM, Al-Ibraheemi A, Qian X. Cytomorphologic spectrum of SMARCB1-deficient soft tissue neoplasms. Am J Clin Pathol. 2021, 156:229-45. 10.1093\/ajcp\/aqaa223","journal-title":"Am J Clin Pathol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1002\/gcc.22992","article-title":"Recurrent loss of chromosome 22 and SMARCB1 deletion in extra-axial chordoma: a clinicopathological and molecular analysis","volume":"60","author":"Wen X","year":"2021","unstructured":"Wen X, Cimera R, Aryeequaye R, et al.. Recurrent loss of chromosome 22 and SMARCB1 deletion in extra-axial chordoma: a clinicopathological and molecular analysis. Genes Chromosomes Cancer. 2021, 60:796-807. 10.1002\/gcc.22992","journal-title":"Genes Chromosomes Cancer"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1038\/s41698-021-00238-4","article-title":"Clinical response to nivolumab in an INI1-deficient pediatric chordoma correlates with immunogenic recognition of brachyury","volume":"5","author":"Williamson LM","year":"2021","unstructured":"Williamson LM, Rive CM, Di Francesco D, et al.. Clinical response to nivolumab in an INI1-deficient pediatric chordoma correlates with immunogenic recognition of brachyury. NPJ Precis Oncol. 2021, 5:103. 10.1038\/s41698-021-00238-4","journal-title":"NPJ Precis Oncol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.5414\/NP301277","article-title":"Poorly differentiated SMARCB1\/INI1-negative chordomas","volume":"40","author":"Zhao J","year":"2021","unstructured":"Zhao J, Feng J, Chen L, Ma Y, Ding D, Wang H. Poorly differentiated SMARCB1\/INI1-negative chordomas. Clin Neuropathol. 2021, 40:36-45. 10.5414\/NP301277","journal-title":"Clin Neuropathol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1097\/MPH.0000000000002402","article-title":"Poorly differentiated chordoma of the clivus with loss of SMARCB1 expression in a pediatric patient: a case report","volume":"44","author":"Yasue S","year":"2022","unstructured":"Yasue S, Ozeki M, Endo S, et al.. Poorly differentiated chordoma of the clivus with loss of SMARCB1 expression in a pediatric patient: a case report. J Pediatr Hematol Oncol. 2022, 44:465-70. 10.1097\/MPH.0000000000002402","journal-title":"J Pediatr Hematol Oncol"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1002\/gcc.22782","article-title":"Molecular characteristics of poorly differentiated chordoma","volume":"58","author":"Shih AR","year":"2019","unstructured":"Shih AR, Chebib I, Deshpande V, Dickson BC, Iafrate AJ, Nielsen GP. Molecular characteristics of poorly differentiated chordoma. Genes Chromosomes Cancer. 2019, 58:804-8. 10.1002\/gcc.22782","journal-title":"Genes Chromosomes Cancer"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.3941\/jrcr.v15i3.4208","article-title":"The CT guided transoral approach: a biopsy technique for a poorly differentiated chordoma in a 5 year old","volume":"15","author":"D'Ortenzio R","year":"2021","unstructured":"D'Ortenzio R, Tolhurst S, Harvey M, Ghag R, Heran MK. The CT guided transoral approach: a biopsy technique for a poorly differentiated chordoma in a 5 year old. J Radiol Case Rep. 2021, 15:1-8. 10.3941\/jrcr.v15i3.4208","journal-title":"J Radiol Case Rep"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1007\/s10143-009-0194-4","article-title":"Proton therapy in chordoma of the base of the skull: a systematic review","volume":"32","author":"Amichetti M","year":"2009","unstructured":"Amichetti M, Cianchetti M, Amelio D, Enrici RM, Minniti G. Proton therapy in chordoma of the base of the skull: a systematic review. Neurosurg Rev. 2009, 32:403-16. 10.1007\/s10143-009-0194-4","journal-title":"Neurosurg Rev"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2020.09.018","article-title":"Carbon ion radiotherapy for sacral chordoma: a retrospective nationwide multicentre study in Japan","volume":"154","author":"Demizu Y","year":"2021","unstructured":"Demizu Y, Imai R, Kiyohara H, et al.. Carbon ion radiotherapy for sacral chordoma: a retrospective nationwide multicentre study in Japan. Radiother Oncol. 2021, 154:1-5. 10.1016\/j.radonc.2020.09.018","journal-title":"Radiother Oncol"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-020-03464-1","article-title":"Carbon ion radiotherapy for skull base chordomas and chondrosarcomas: a systematic review and meta-analysis of local control, survival, and toxicity outcomes","volume":"147","author":"Lu VM","year":"2020","unstructured":"Lu VM, O'Connor KP, Mahajan A, Carlson ML, Van Gompel JJ. Carbon ion radiotherapy for skull base chordomas and chondrosarcomas: a systematic review and meta-analysis of local control, survival, and toxicity outcomes. J Neurooncol. 2020, 147:503-13. 10.1007\/s11060-020-03464-1","journal-title":"J Neurooncol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/216123-a-rare-case-of-adult-poorly-differentiated-chordoma-of-the-skull-base-with-rapid-progression-and-systemic-metastasis-a-review-of-the-literature","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:13:56Z","timestamp":1707509636000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/216123-a-rare-case-of-adult-poorly-differentiated-chordoma-of-the-skull-base-with-rapid-progression-and-systemic-metastasis-a-review-of-the-literature"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,3]]},"references-count":35,"URL":"https:\/\/doi.org\/10.7759\/cureus.51605","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1,3]]}}}